Literature DB >> 30061942

Colony stimulating factor-1 receptor promotes proliferation, migration and invasion in the human nasopharyngeal carcinoma 6-10B cell line via the phosphoinositide 3-kinase/Akt pathway.

Jiayu Chen1,2, Yanrong Hao2, Jiaxin Chen2, Li Huang1, Wen Ao2, Jiao Yang2, Lei Li2, Junping Heng2, Zhaohon Chen2, Wuqing Liang2, Xin Hao2, Weiwei Gao2.   

Abstract

The present study aimed to investigate the effects of colony-stimulating factor-1 receptor (CSF-1R) on proliferation, migration and invasion in the human nasopharyngeal carcinoma (NPC) 6-10B cell line, and to investigate the possible underlying mechanisms. Using a lentiviral transfection method, a virus carrying the CSF-1R gene was transfected into 6-10B cells. The expression of CSF-1R was then detected by reverse transcription-quantitative polymerase chain reaction and western blot analysis, and was revealed to be markedly enhanced in 6-10B cells. Subsequently, an MTT assay was performed to assess cell proliferative ability, and flow cytometric analysis was utilized to measure the apoptotic rate of the cells. Wound healing and Transwell assays were also performed to observe cell migration and invasion capabilities. Additionally, western blot analysis was used to detect the protein expression of the proliferation and apoptosis signaling factors cyclin D1, B-cell lymphoma 2, Bcl-2-associated X protein, and phosphorylated and total extracellular protein kinase B (Akt/PKB) in 6-10B cells. The results showed that CSF-1R overexpression promoted the proliferation, migration and invasion of the 6-10B cells. The corresponding mechanism may be associated with activation of the phosphoinositide 3-kinase/Akt pathway, which promotes cell survival and proliferation. These results indicated a potential molecular target for the treatment of NPC.

Entities:  

Keywords:  B-cell lymphoma 2; Bcl-2-associated X protein; colony-stimulating factor-1 receptor; cyclin D1; invasion; migration; nasopharyngeal carcinoma; phosphoinositide 3-kinase/Akt pathway; proliferation

Year:  2018        PMID: 30061942      PMCID: PMC6063050          DOI: 10.3892/ol.2018.8750

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Nasopharyngeal carcinoma: the next challenges.

Authors:  Albiruni R A Razak; Lillian L Siu; Fei-Fei Liu; Emma Ito; Brian O'Sullivan; Kelvin Chan
Journal:  Eur J Cancer       Date:  2010-05-05       Impact factor: 9.162

Review 3.  PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

4.  The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma.

Authors:  D T Chua; J S Sham; W I Wei; W K Ho; G K Au
Journal:  Cancer       Date:  2001-12-01       Impact factor: 6.860

5.  Evaluation of ER, PgR, HER-2, Ki-67, cyclin D1, and nm23-H1 as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer.

Authors:  Xi-ru Li; Mei Liu; Yan-jun Zhang; Jian-dong Wang; Yi-qiong Zheng; Jie Li; Bing Ma; Xin Song
Journal:  Med Oncol       Date:  2010-09-16       Impact factor: 3.064

6.  CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma.

Authors:  Piotr Czapiewski; Marzena Wełnicka-Jaśkiewicz; Barbara Seroczyńska; Jarosław Skokowski; Aleksandra Sejda; Jolanta Szade; Claudia Wiewiora; Wojciech Biernat; Anna Żaczek
Journal:  Pol J Pathol       Date:  2015-09       Impact factor: 1.072

7.  The macrophage colony-stimulating factor 1 response signature in breast carcinoma.

Authors:  Andrew H Beck; Inigo Espinosa; Badreddin Edris; Rui Li; Kelli Montgomery; Shirley Zhu; Sushama Varma; Robert J Marinelli; Matt van de Rijn; Robert B West
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

Review 8.  Exploiting receptor tyrosine kinase co-activation for cancer therapy.

Authors:  Aik-Choon Tan; Simon Vyse; Paul H Huang
Journal:  Drug Discov Today       Date:  2016-07-21       Impact factor: 7.851

9.  The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor.

Authors:  Agnieszka Swierczak; Andrew D Cook; Jason C Lenzo; Christina M Restall; Judy P Doherty; Robin L Anderson; John A Hamilton
Journal:  Cancer Immunol Res       Date:  2014-04-29       Impact factor: 11.151

10.  hcrcn81 promotes cell proliferation through Wnt signaling pathway in colorectal cancer.

Authors:  Yao Chen; Tingting Jiang; Lihong Shi; Kunyan He
Journal:  Med Oncol       Date:  2015-11-25       Impact factor: 3.064

View more
  3 in total

1.  Structural and functional characterization of β2 -glycoprotein I domain 1 in anti-melanoma cell migration.

Authors:  Shr-Jeng Jim Leu; Tzong-Yi Lee; Shu-Wei Cheng; Meng-Ying Tsai; Yu-Shan Lin; Tzeon-Jye Chiou; Kai-Yao Huang; An-Na Chiang
Journal:  Cancer Sci       Date:  2019-05-15       Impact factor: 6.716

2.  SASH1 Suppresses the Proliferation and Invasion of Human Skin Squamous Cell Carcinoma Cells via Inhibiting Akt Cascade.

Authors:  Shang-Zhou Chen; Yang Zhang; Shu-Ying Lei; Fa-Qiong Zhou
Journal:  Onco Targets Ther       Date:  2020-05-25       Impact factor: 4.147

3.  Overexpression of macrophage-colony stimulating factor-1 receptor as a prognostic factor for survival in cancer: A systematic review and meta-analysis.

Authors:  Huaqing Mo; Yanrong Hao; Yanru Lv; Zenan Chen; Jingyi Shen; Shu Zhou; MengJie Yin
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.